Exome Asset Management’s Instil Bio TIL Stock Holding History

Exome Asset Management’s Portfolio TIL Stock Details TIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-16,200	Closed	-$337K	–	94
2025 Q2	$337K	Buy	+16,200	New	+$339K	0.25%	56

Other funds holding TIL

CVV

Curative Ventures V Dallas, Texas $15.6M AUM 52.53% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Exome Asset Management's TIL Position: Q3 2025 in Review

Exome Asset Management sold out of Instil Bio (TIL) in Q3 2025, closing a stake of 16,200 shares — an estimated $337K sold.

Exome Asset Management first reported a position in TIL in Q2 2025 and held it in 1 quarter. The position peaked at $337K in Q2 2025. 34 funds tracked by Wall St. Rank hold TIL as of Q3 2025.

Exome Asset Management reported no remaining Instil Bio position as of Q3 2025 after selling out during the quarter.
Exome Asset Management sold 16,200 Instil Bio shares in Q3 2025, an estimated $337K.
Exome Asset Management first reported a position in Instil Bio in Q2 2025 and held it in 1 quarter.
Exome Asset Management's Instil Bio position peaked at $337K in Q2 2025.
34 funds tracked by Wall St. Rank held Instil Bio as of Q3 2025.

Based on Exome Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.